‌

US Patent 7674906 Tetracyclic immunomodulatory compounds

Patent 7674906 was granted and assigned to Active Biotech AB on March, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Active Biotech AB

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76749060

Patent Inventor Names

Lars Olof Göran Pettersson0

Muhammed Kamal Uddin0

Philip Huxley0

Chris James Brennan0

Dorthe da Graca Thrige0

Filippo Magaraci0

Ian Richard Matthews0

Date of Patent

March 9, 2010

Patent Application Number

105375380

Date Filed

December 12, 2003

Patent Primary Examiner

‌

Rita J Desai

Patent abstract

The present invention relates to novel heterocyclic compounds, to methods for their preparation, to compositions containing them, and to methods and use for clinical treatment of medical conditions which may benefit from immunomodulation, including rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis. More particularly, the present invention relates to novel heterocyclic compounds, which are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28.